Plantar-palmar erytrodysaestesi. En ny og relativt hyppigt forekommende bivirkning ved antineoplastisk behandling

Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › fagfællebedømt

Standard

Plantar-palmar erytrodysaestesi. En ny og relativt hyppigt forekommende bivirkning ved antineoplastisk behandling. / Risum, Signe; Langer, Seppo W.

I: Ugeskrift for Laeger, Bind 165, Nr. 33, 11.08.2003, s. 3161-2.

Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › fagfællebedømt

Harvard

Risum, S & Langer, SW 2003, 'Plantar-palmar erytrodysaestesi. En ny og relativt hyppigt forekommende bivirkning ved antineoplastisk behandling', Ugeskrift for Laeger, bind 165, nr. 33, s. 3161-2.

APA

Risum, S., & Langer, S. W. (2003). Plantar-palmar erytrodysaestesi. En ny og relativt hyppigt forekommende bivirkning ved antineoplastisk behandling. Ugeskrift for Laeger, 165(33), 3161-2.

Vancouver

Risum S, Langer SW. Plantar-palmar erytrodysaestesi. En ny og relativt hyppigt forekommende bivirkning ved antineoplastisk behandling. Ugeskrift for Laeger. 2003 aug. 11;165(33):3161-2.

Author

Risum, Signe ; Langer, Seppo W. / Plantar-palmar erytrodysaestesi. En ny og relativt hyppigt forekommende bivirkning ved antineoplastisk behandling. I: Ugeskrift for Laeger. 2003 ; Bind 165, Nr. 33. s. 3161-2.

Bibtex

@article{9cb411fcbdde4300aa921f221558fa6d,
title = "Plantar-palmar erytrodysaestesi. En ny og relativt hyppigt forekommende bivirkning ved antineoplastisk behandling",
abstract = "Palmar-plantar erythrodysesthesia (PPE, hand-foot syndrome) is a relatively frequent cutaneous toxicity related to antineoplastic treatment with e.g. fluorouracil, capecitabine, and liposomal doxorubicin. It usually presents as paresthesia and painful erythema of the palms and soles and may lead to ulceration of the skin. The symptoms are dose-dependent, and the condition may be dose-limiting. Two cases of chemotherapy-associated PPE are presented.",
keywords = "Antimetabolites, Antineoplastic/adverse effects, Antineoplastic Agents/adverse effects, Capecitabine, Deoxycytidine/adverse effects, Dose-Response Relationship, Drug, Doxorubicin/adverse effects, Drug Eruptions/etiology, Female, Fluorouracil/adverse effects, Foot Dermatoses/chemically induced, Hand Dermatoses/chemically induced, Humans, Male, Middle Aged, Syndrome",
author = "Signe Risum and Langer, {Seppo W}",
year = "2003",
month = aug,
day = "11",
language = "Dansk",
volume = "165",
pages = "3161--2",
journal = "Ugeskrift for Laeger",
issn = "0041-5782",
publisher = "Almindelige Danske Laegeforening",
number = "33",

}

RIS

TY - JOUR

T1 - Plantar-palmar erytrodysaestesi. En ny og relativt hyppigt forekommende bivirkning ved antineoplastisk behandling

AU - Risum, Signe

AU - Langer, Seppo W

PY - 2003/8/11

Y1 - 2003/8/11

N2 - Palmar-plantar erythrodysesthesia (PPE, hand-foot syndrome) is a relatively frequent cutaneous toxicity related to antineoplastic treatment with e.g. fluorouracil, capecitabine, and liposomal doxorubicin. It usually presents as paresthesia and painful erythema of the palms and soles and may lead to ulceration of the skin. The symptoms are dose-dependent, and the condition may be dose-limiting. Two cases of chemotherapy-associated PPE are presented.

AB - Palmar-plantar erythrodysesthesia (PPE, hand-foot syndrome) is a relatively frequent cutaneous toxicity related to antineoplastic treatment with e.g. fluorouracil, capecitabine, and liposomal doxorubicin. It usually presents as paresthesia and painful erythema of the palms and soles and may lead to ulceration of the skin. The symptoms are dose-dependent, and the condition may be dose-limiting. Two cases of chemotherapy-associated PPE are presented.

KW - Antimetabolites, Antineoplastic/adverse effects

KW - Antineoplastic Agents/adverse effects

KW - Capecitabine

KW - Deoxycytidine/adverse effects

KW - Dose-Response Relationship, Drug

KW - Doxorubicin/adverse effects

KW - Drug Eruptions/etiology

KW - Female

KW - Fluorouracil/adverse effects

KW - Foot Dermatoses/chemically induced

KW - Hand Dermatoses/chemically induced

KW - Humans

KW - Male

KW - Middle Aged

KW - Syndrome

M3 - Tidsskriftartikel

C2 - 12968412

VL - 165

SP - 3161

EP - 3162

JO - Ugeskrift for Laeger

JF - Ugeskrift for Laeger

SN - 0041-5782

IS - 33

ER -

ID: 247892127